Pharma & Life Sciences

Companies at Oncology & Immunology Innovation Partnering & Licensing Summit

This event has ended. The listing below is kept for reference.

13 organisations are named on published listings for Oncology & Immunology Innovation Partnering & Licensing Summit: 13 companies on stage.

From the listings Oncology & Immunology Innovation Partnering & Licensing Summit prints on its own site. No registration data, and no individual attendees.

The essentials

Event details

Dates
9 September 2026 to 10 September 2026
Location
Boston, United States
Venue
Boston, MA
Industry
Pharma & Life Sciences
Companies listed
13

From the speaker listing

Companies on stage (13)

Organisations named beside a speaker on the speaker listings published for Oncology & Immunology Innovation Partnering & Licensing Summit.

  • Daiichi Sankyo
  • Ipsen Pharma
  • Astellas Pharma
  • Merck & Co
  • Inc
  • Boehringer Ingelheim
  • Johnson & Johnson
  • UCB
  • Deep Track Capital
  • Eli Lilly & Co
  • Takeda Pharmaceutical
  • VU Venture Partners
  • AstraZeneca

Last checked 2026-09-11.

Agenda themes

Topics covered

  • Medical & Pharma

Ahead of the event

From the published list to a ranked target list

Published listings for Oncology & Immunology Innovation Partnering & Licensing Summit name 13 organisations, 13 companies on stage. Your team needs the people in them who match your ICP, ranked, with account context, in the sequencer it already uses. Luminik sources the attendee picture from the event's public directory and the organisations around it, enriches it against your ICP, and sequences it weeks ahead of the event. Capture at the event writes straight to Salesforce or HubSpot the same day, and attribution ties the pipeline back to the spend.

Common questions

Frequently asked

Which companies attend Oncology & Immunology Innovation Partnering & Licensing Summit?
13 organisations are named on published listings for Oncology & Immunology Innovation Partnering & Licensing Summit: 13 companies on stage, including Daiichi Sankyo, Ipsen Pharma, Astellas Pharma, Merck & Co, Inc. That is the listed line-up rather than a registration list, so it names no individual attendee.

Oncology & Immunology Innovation Partnering & Licensing Summit is a trademark of its organiser. This page is an independent summary of listings published for the event. Being listed here is not an endorsement of the event, of Luminik, or of anything else. Luminik is not affiliated with the event.